EMD-25449

Single-particle
30.0 Å
EMD-25449 Deposition: 19/11/2021
Map released: 22/12/2021
Last modified: 17/01/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-25449

Archive Files (Depositor)

Primary 3D volume (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

RFN_131, a Ferritin-based Nanoparticle Vaccine Candidate Displaying the SARS-CoV-2 Receptor-Binding Domain

EMD-25449

Single-particle
30.0 Å
EMD-25449 Deposition: 19/11/2021
Map released: 22/12/2021
Last modified: 17/01/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Severe acute respiratory syndrome coronavirus 2
Sample: RFN_131, a Ferritin-based Nanoparticle Vaccine Candidate Displaying the SARS-CoV-2 Receptor-Binding Domain

Deposition Authors: Thomas PV , Smith C, Chen WH , Sankhala RS , Hajduczki A, Choe M , Martinez E , Chang W, Peterson CE , Karch C , Gohain N , Kannadka CB, de Val N , Joyce MG , Modjarrad K
SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity